Conning Has Raised Amgen (AMGN) Holding; Royal Gold Has 1.17 Sentiment

May 24, 2018 - By Richard Conner

Royal Gold, Inc. (NASDAQ:RGLD) Logo

Conning Inc increased Amgen Inc (AMGN) stake by 3.73% reported in 2017Q4 SEC filing. Conning Inc acquired 7,773 shares as Amgen Inc (AMGN)’s stock declined 2.99%. The Conning Inc holds 215,897 shares with $37.54M value, up from 208,124 last quarter. Amgen Inc now has $119.84B valuation. The stock increased 0.89% or $1.58 during the last trading session, reaching $179.94. About 1.87M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since May 24, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Royal Gold Inc (RGLD) investors sentiment decreased to 1.17 in 2017 Q4. It’s down -0.24, from 1.41 in 2017Q3. The ratio has dropped, as 124 active investment managers started new and increased stock positions, while 106 reduced and sold stakes in Royal Gold Inc. The active investment managers in our database now own: 47.73 million shares, up from 46.63 million shares in 2017Q3. Also, the number of active investment managers holding Royal Gold Inc in top ten stock positions was flat from 4 to 4 for the same number . Sold All: 27 Reduced: 79 Increased: 77 New Position: 47.

More notable recent Royal Gold, Inc. (NASDAQ:RGLD) news were published by: Benzinga.com which released: “Earnings Preview For Royal Gold” on May 02, 2018, also Globenewswire.com with their article: “Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National …” published on May 15, 2018, Seekingalpha.com published: “Royal Gold’s (RGLD) CEO Tony Jensen on Q3 2018 Results – Earnings Call Transcript” on May 03, 2018. More interesting news about Royal Gold, Inc. (NASDAQ:RGLD) were released by: Investorplace.com and their article: “Top 20 Gold Stocks to Buy Despite Irrational Markets” published on May 21, 2018 as well as Streetinsider.com‘s news article titled: “Royal Gold (RGLD) Tops Q3 EPS by 5c, Beats on Revenues” with publication date: May 02, 2018.

Analysts await Royal Gold, Inc. (NASDAQ:RGLD) to report earnings on August, 8. They expect $0.41 EPS, up 32.26% or $0.10 from last year’s $0.31 per share. RGLD’s profit will be $26.84 million for 53.85 P/E if the $0.41 EPS becomes a reality. After $0.48 actual EPS reported by Royal Gold, Inc. for the previous quarter, Wall Street now forecasts -14.58% negative EPS growth.

The stock increased 0.51% or $0.45 during the last trading session, reaching $88.32. About 246,845 shares traded. Royal Gold, Inc. (RGLD) has risen 22.48% since May 24, 2017 and is uptrending. It has outperformed by 10.93% the S&P500.

Royal Gold, Inc., together with its subsidiaries, acquires and manages precious metal streams, royalties, and similar interests. The company has market cap of $5.78 billion. It focuses on acquiring stream and royalty interests or to finance projects that are in production or in development stage in exchange for stream or royalty interests. It has a 100.48 P/E ratio. As of June 30, 2017, the firm owned stream interests in 4 producing property and 2 development stage properties; and owned royalty interests in 35 producing properties, 18 development stage properties, and 135 exploration stage properties.

Asa Gold & Precious Metals Ltd holds 9.35% of its portfolio in Royal Gold, Inc. for 190,000 shares. St. James Investment Company Llc owns 798,458 shares or 7.58% of their US portfolio. Moreover, Kopernik Global Investors Llc has 4.81% invested in the company for 318,331 shares. The Nebraska-based America First Investment Advisors Llc has invested 4.25% in the stock. Pring Turner Capital Group Inc, a California-based fund reported 40,160 shares.

Since January 1, 0001, it had 0 insider buys, and 6 insider sales for $776,400 activity.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: 247Wallst.com which released: “Amgen Wins Another FDA Approval” on May 22, 2018, also Streetinsider.com with their article: “Amgen (AMGN), NCI Enter Pact to Improve Symptom Management During Cancer” published on May 24, 2018, 247Wallst.com published: “Amgen’s Novel Migraine Treatment Gets Key Approval” on May 18, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “Amgen to collaborate on patient-centric cancer management initiative” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “Expanded label for Amgen’s Repatha approved in Europe” with publication date: May 16, 2018.

Conning Inc decreased National Oilwell Varco Inc (NYSE:NOV) stake by 16,648 shares to 9,568 valued at $345,000 in 2017Q4. It also reduced Dowdupont Inc stake by 401,506 shares and now owns 171,896 shares. Magellan Midstream Prtnrs Lp (NYSE:MMP) was reduced too.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Wednesday, January 20 by Credit Suisse. The stock of Amgen Inc. (NASDAQ:AMGN) has “Equal-Weight” rating given on Thursday, April 5 by Barclays Capital. Mizuho initiated it with “Buy” rating and $164 target in Tuesday, November 8 report. The stock has “Buy” rating by Oppenheimer on Monday, June 26. The firm earned “Buy” rating on Monday, February 8 by Argus Research. Mizuho maintained the stock with “Buy” rating in Sunday, October 29 report. The firm earned “Buy” rating on Thursday, February 1 by Cowen & Co. The firm has “Buy” rating by Jefferies given on Thursday, September 28. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Market Perform” rating by Leerink Swann on Friday, February 5. On Friday, August 26 the stock rating was initiated by Gabelli with “Hold”.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.23, from 0.99 in 2017Q3. It improved, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Chevy Chase Tru Holdings has invested 0.48% in Amgen Inc. (NASDAQ:AMGN). Roof Eidam Maycock Adv holds 5,145 shares. 1,806 were accumulated by Lourd Ltd Liability. Rafferty Asset Management Limited Liability Company has invested 0.03% in Amgen Inc. (NASDAQ:AMGN). California-based Doheny Asset Mngmt Ca has invested 0.62% in Amgen Inc. (NASDAQ:AMGN). Nordea Inv Ab has 5.83M shares for 2.39% of their portfolio. First Citizens Bancshares And Tru Com holds 0.6% or 25,545 shares in its portfolio. Beacon Finance Gru reported 1.36% stake. 92,346 are held by Marsico Capital Mgmt Ltd Liability. 37,198 are owned by First Trust. Moreover, Burns J W And Incorporated Ny has 0.88% invested in Amgen Inc. (NASDAQ:AMGN) for 19,918 shares. Focused Wealth Mgmt has 1,752 shares for 0.1% of their portfolio. Fund Mgmt Sa holds 0.05% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 53,845 shares. First Advsrs LP reported 0.26% in Amgen Inc. (NASDAQ:AMGN). Hrt Fin Limited Company stated it has 0.22% of its portfolio in Amgen Inc. (NASDAQ:AMGN).

Since December 12, 2017, it had 0 insider buys, and 6 selling transactions for $1.64 million activity. On Wednesday, February 14 the insider Harper Sean E sold $265,625.

Royal Gold, Inc. (NASDAQ:RGLD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>